Pharma & Biopharma Manufacturing
Everest Medicines Announces Positive Topline Data from Phase 3 Trial of Etrasimod for Ulcerative Colitis in Asia
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
July 16, 2024 | News
Merck Life Science Launches First GMP Compliant Manufacturing Line for Cell Culture Media in China
Merck Life Science is thrilled to announce the commencement of commercial production at our first Good Manufacturing Practice (GMP) compliant manuf...
July 16, 2024 | News
Porton J-STAR Secures Two-Year Contract with Enabling Technologies Consortium for Co-Processing Platform Development
Porton J-STAR announced that Enabling Technologies Consortium (ETC) has awarded a two-year contract to J-STAR to collaborate on "Co-processing Platfo...
July 10, 2024 | News
CBC Group and Hasten Biopharmaceutical Acquire Asset Rights of 14 Branded Products from Celltrion in Major Pan-Asia Expansion
CBC Group (“CBC”), Asia’s largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its control...
July 01, 2024 | News
Thermo Fisher Scientific Introduces Biobased Films for Bioprocessing Containers to Enhance Sustainability in Biologics Manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, is contributing to the sustainability of biologics therapy manufacturing by leveraging ...
July 01, 2024 | News
Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability
Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...
July 01, 2024 | News
Cytiva Introduces Supor Prime Filters to Enhance High-Concentration Biologic Drug Manufacturing
Global life sciences leader Cytiva is addressing the distinct filtration needs of customers manufacturing high-concentration biologic drugs with its Supor ...
June 28, 2024 | News
Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.
Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...
June 25, 2024 | News
Bota Bio and NHU Announce Successful Commercialization of Collaborative Biomanufacturing Project
Bota Bio, a global industrial biotechnology company specializing in sustainable biomanufacturing solutions, and NHU, a global leader in the fine chemical i...
June 25, 2024 | News
YolTech Partners with KACTUS to Commercialize Breakthrough DNA Editor YolCas12TM in Greater China
YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery for in vivo gene editing therapies, has partnered with KACT...
June 19, 2024 | News
FDA Clears Zymeworks' ZW171 for Mesothelin-Expressing Cancers
“We are excited to reach this R&D milestone with ZW171, reflecting our commitment to advancing innovative therapies for cancer treatment,...
June 18, 2024 | News
Ascentage Pharma Secures $1.3 Billion Deal with Takeda for Global Rights to Olverembatinib
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas. ...
June 17, 2024 | News
Ethypharm Expands Portfolio with Acquisition of Mesalazine Suppository by Chinese Affiliate
Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals Ltd, from...
June 14, 2024 | News
Bespak Expands Low GWP Inhaler Production with New High-Speed Filling Equipment
Bespak, a leading contract development and manufacturing organisation (CDMO) focused on orally inhaled and nasal drug-device combination products, is today...
June 12, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
